Date of Award
Summer 8-31-2025
Document Type
Open Access Thesis
Degree Name
Master of Science (MS)
Department
Physics, Applied
First Advisor
Jonathan Celli
Second Advisor
Chandra Yelleswarapu
Third Advisor
Akira Sone
Abstract
Background: Photodynamic Therapy (PDT) utilizes specific wavelengths of light to activate photosensitizing chemical compounds, known as photosensitizers, which induce the generation of cytotoxic reactive oxygen species (ROS) for the targeted destruction of cancer cells. Among various photosensitizers for PDT, Protoporphyrin IX (PpIX) is widely employed in oncology and dermatology due to its natural in situ generation via the metabolic conversion of 5- aminolevulinic acid (ALA), a non-phototoxic prodrug. Systemic administration of ALA after 3-6 hr drug delay leads to peak PpIX accumulation in tissues, facilitating therapeutic and diagnostic applications. However, PpIX can persist in the skin for 24–48 hours post-treatment, posing a risk of phototoxicity, especially in patients with sensitive skin. Monitoring residual PpIX is therefore essential for evaluating treatment efficacy and determining safe discharge timing. By integrating frugal engineering with clinically validated fluorescence detection principles, this study addresses an unmet need in PDT patient management. It aims to develop an affordable, portable Cutaneous PpIX Detection (CPD) device for real-time fluorescence (FL) monitoring, leveraging the distinct optical properties of PpIX. v Methods: A point-of-care portable Cutaneous PpIX Detection (CPD) device was designed, integrating a 405 nm LED excitation source, a 600 nm long-pass optical filter, and a photodiode sensor. The system was calibrated using standardized PpIX solutions and validated with hydrogel phantom models, 3D cancer cell cultures, and murine models. Results: The CPD device demonstrated high sensitivity in detecting low PpIX concentrations, correlating well with commercial fluorescence detection systems. The cost-effective design enhances clinical feasibility in resource-limited settings. Conclusions: This study presents a viable solution for post-PDT PpIX monitoring, thereby improving patient management and enhancing PDT accessibility. Future advancements will explore automated signal interpretation and sustainable power sources for broader biomedical applications.
Recommended Citation
Rasel, Md Asaduzzaman, "Low-cost Cutaneous Protoporphyrin IX (PPIX) Detection (CPD) device for follow-up monitoring of patients after photodynamic therapy" (2025). Graduate Masters Theses. 913.
https://scholarworks.umb.edu/masters_theses/913
Included in
Bioimaging and Biomedical Optics Commons, Biological and Chemical Physics Commons, Biomedical Devices and Instrumentation Commons, Biotechnology Commons, Engineering Physics Commons, Optics Commons, Physical Chemistry Commons, Quantum Physics Commons
Comments
Free and open access to this Campus Access Thesis is made available to the UMass Boston community by ScholarWorks at UMass Boston. Those not on campus and those without a UMass Boston campus username and password may gain access to this thesis through Interlibrary Loan. If you have a UMass Boston campus username and password and would like to download this work from off-campus, click on the “Off-Campus Users” button.